SCHEMBL7233236

SCHEMBL7233236

CSc1cc(-c2cccnc2)nn1-c1ccc([N+](=O)[O-])cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP8 P40818 1/20 0.48
CA1 P00915 2/20 0.47
CA2 P00918 2/20 0.47
CA9 Q16790 2/20 0.47
CA12 O43570 1/20 0.47
MAPT P10636 5/20 0.43
CHRNB2 P17787 1/20 0.43
CHRNA5 P30532 1/20 0.43
CHRNA4 P43681 1/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
PKM P14618 2/20 0.43
ALDH1A1 P00352 3/20 0.42
RAB9A P51151 2/20 0.42
NPC1 O15118 1/20 0.42
NFKB1 P19838 1/20 0.42
NFKB2 Q00653 1/20 0.42
RELA Q04206 1/20 0.42
KMT2A Q03164 3/20 0.42
GAA P10253 2/20 0.42
NPSR1 Q6W5P4 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7328104 0.82 NPY5R (0.53) USP8CA1CA2CA9CA12
SCHEMBL7234719 0.81 EPHX2 (0.60) USP8CA1CA2CA9CA12
SCHEMBL7327417 0.80 USP8 (0.46) USP8CA1CA2CA9CA12
SCHEMBL7239521 0.79 PKM (0.48) USP8CA1CA2CA9CA12
SCHEMBL7314318 0.79 USP8 (0.48) USP8CA1CA2CA9CA12
SCHEMBL7233586 0.79 MAPT (0.53) USP8CA1CA2CA9CA12
SCHEMBL7315513 0.79 CA1 (0.52) USP8CA1CA2CA9CA12
SCHEMBL7325689 0.78 MAPT (0.47) USP8CA1CA2CA9CA12
SCHEMBL15070459 0.78 MMP2 (0.57) USP8CA1CA2CA9CA12
SCHEMBL7236975 0.77 USP8 (0.44) USP8CA1CA2CA9CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6506747-B1 Method of treating an inflammatory disease which comprises administering to a patient in need of such treatment-a N-(4-(5-Ethyl-3-pyridin-3-yl-pyrazol-1-yl)phenyl)pyridine-3-carboxamide; BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. 2003-01-14 US disclosed